共 114 条
[1]
Hong CM(2014)Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation Nucl Med Commun 35 1119-1126
[2]
Lee WK(2010)Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma Eur J Nucl Med Mol Imaging 37 821-828
[3]
Jeong SY(2006)Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal J Nucl Med 47 648-654
[4]
Lee SW(2016)Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer Biomed Res Int 2016 1680464-181
[5]
Ahn BC(2015)Radioiodine scan index: a simplified, quantitative treatment response parameter for metastatic thyroid carcinoma Nucl Med Mol Imaging 49 174-269
[6]
Lee J(2007)Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients Nat Clin Pract Endocrinol Metab 3 260-3290
[7]
Salvatori M(2010)Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal J Clin Endocrinol Metab 95 3283-1027
[8]
Luster M(2005)OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J Nucl Med 46 1023-546
[9]
Hanscheid H(2000)The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications Radiographics 20 533-323
[10]
Lassmann M(1999)Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer Q J Nucl Med 43 313-1214